Back to
Aberdeen Group plc
QNRX3 quarters
Position history for
Aberdeen Group plc's holdings in QUOIN PHARMACEUTICALS LTD
Yes. Aberdeen Group holds 75,000 shares of QNRX (Quoin Pharmaceuticals), worth $363,000, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Aberdeen Group has held QNRX since Q4 2025, across 3 quarterly 13F filings.
Current Value
$363,000
Current Shares
75,000
Total Value Change
-$719,250
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of QNRX: Woodline Partners LP, MILLENNIUM MANAGEMENT LLC